Journals / Retina-Vitreus / 2005 / Cilt: 13 - Sayı: 3

Triamcinolone-assisted posterior hyaloid removal and internal limiting membrane peeling in diffuse diabetic macular edema

Diffüz diyabetik maküla ödemli olgularda triamsinolon yardımı ile arka hyaloid ayrılması ve iç limitan membran soyulması

Pages
197–200
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, controlled studies with a long follow-up period are required for a more reliable conclusion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the effectiveness of triamcinolone-assisted pars plana vitrectomy (PPV) and internal limiting membrane (ILM) removal in diffuse diabetic macular edema.
📊
Key Findings & Data:Materials and Methods: In this study, 16 eyes of 16 patients with diabetic macular edema were evaluated.
💡
Conclusion & Impact:However, controlled studies with a long follow-up period are required for a more reliable conclusion.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Diabetik retinopati · Triamsinolon · Vitrektomi

Abstract

Purpose: To evaluate the effectiveness of triamcinolone-assisted pars plana vitrectomy (PPV) and internal limiting membrane (ILM) removal in diffuse diabetic macular edema. Materials and Methods: In this study, 16 eyes of 16 patients with diabetic macular edema were evaluated. Triamcinoloneassisted PPV with indocyanine-assisted ILM removal was performed in all eyes. Main outcome measures were the foveal thickness changes measured with optical coherence tomography, and preoperative and postoperative visual acuities. Wilcoxon signed rank test was used in statistical analysis. Results: Mean follow-up period was 4.2 months (range; 1 to 6). Mean foveal thickness ± Standard deviation (SD) was 534.8 82.7 µm preoperatively and 273.7 32.6 µm postoperatively (p=0.000). LogMAR visual acuity ± SD was 0.78±0.23 preoperatively and 0.60±0.24 postoperatively (p=0.005). Visual acuity improved by 2 or more lines in 9 eyes (56.2%) remained stable in 7 eyes (43.8%). No recurrence of macular edema was observed in any of the eyes. No major intraoperative complications were encountered in any of the eyes. Mild progression of nuclear sclerosis in 2 eyes (12.5%) and transient increase of intraocular pressure in 3 eyes (18.7%) were observed during the follow-up period. Conclusion: Posterior hyaloid could be visualized and removed easily using triamcinolone during PPV. In eyes with diffuse diabetic macular edema, triamcinolone-assisted PPV with ILM removal appears to be an effective method in the early postoperative period. However, controlled studies with a long follow-up period are required for a more reliable conclusion.

Özet

Amaç: Diffüz diyabetik maküla ödemli olgularda triamsinolon yardımı ile pars plana vitrektomi (PPV) ve iç limitan membran (İLM) soyulmasının etkinliğini araştırmak. Gereç ve Yöntem: Bu çalışmada, diffüz diyabetik maküla ödemi olan 16 hastanın 16 gözü değerlendirildi. Bu gözlere triamsinolon yardımı ile PPV uygulandı ve indosiyanin yeşili yardımı ile İLM soyuldu. Çalışmamızda araştırdığımız ana parametreler; optik koherens tomografi (OCT) ile ölçülen fovea kalınlığı, pre ve postoperatif görme keskinliği idi. İstatistiksel analizlerde Wilcoxon signed rank testi kullanıldı. Bulgular: Olgular ortalama 4.2 ay (1-6 ay) süre ile takip edildi. Ortalama fovea kalınlığı ± Standart Deviasyon (SD) preoperatif 534.8 82.7 µm iken, postoperatif 273.7 32.6 µm bulundu (p=0.000). LogMAR görme keskinliği ± SD preoperatif 0.78 0.23 iken, postoperatif 0.60 0.24 idi (p=0.005). Dokuz gözde (%56.2) görme keskinliğinde 2 sıra ve üzerinde artış olurken, 7 gözde (%43.8) görme keskinliği aynı düzeyde kaldı. Hiçbir olguda maküla ödeminde nüks gözlenmedi. Hiçbir olguda PPV'ye ya da triamsinolon kullanımına bağlı ciddi peroperatif komplikasyon gelişmedi. Takip süresince 2 gözde (%12.5) lens bulanıklığında hafif artış, 3 gözde de (%18.7) geçici göz içi basınç artışı saptandı. Sonuç: Triamsinolon kullanımının, PPV sırasında arka hyaloidi daha görünür bir duruma getirerek soyulmasını kolaylaştırdığı gözlendi. Diffüz diyabetik maküla ödemli olgularda, triamsinolon yardımıyla PPV ile birlikte İLM soyulmasının erken postoperatif dönemde etkin bir yöntem olabileceği düşünüldü. Ancak, bu konuda daha sağlıklı bir sonuca varabilmek için daha uzun takip süreli ve kontrollü çalışmalara gereksinim vardır.

🔖

Cite This Article

ÇELİK, E., YANYALP, A., HOROZOĞLU, F., ERÇALIK, Y., NOHUTÇU, A. F. (2005). Triamcinolone-assisted posterior hyaloid removal and internal limiting membrane peeling in diffuse diabetic macular edema. Retina-Vitreus, Cilt: 13 - Sayı: 3, 197–200. https://ajindex.com/articles/308112

References (17)

  1. Klein R, Klein BE, Moss SE: Visual impairment in diabetes. Ophthalmology 1984; 91: 1-9
  2. Bresnick GH: Diabetic macular edema: a review. Ophthalmology 1986;93:989-997
  3. Bresnick GH: Diabetic maculopathy: a critical review highlighting diffuse macular edema. Ophthalmology 1983;90:1301-1317
  4. Lee CM, Oik RJ: Modified grid laser photocoagulation for diffuse diabetic macular edema: long term visual results. Ophthalmology 1991;98:1594-1602
  5. Gelişken O, Yazıcı B: Maküla ödeminde tedavi. Ret-Vit 2000;8:27-33
  6. Lewis H, Abrams GW, Blumekranz MS, et al: Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992; 99: 753-759
  7. Ikeda T, Sato K, Katano T, et al: Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina 2000; 20: 220-222
  8. Machemer R, Sugita G, Tano Y: Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979,77:171-180
  9. Funatsu H, Yamashita H, Ikeda T, et al: Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2003; 110: 1690-1696
  10. Karaçorlu M, Özdemir H, Alacalı N, et al: Diffüz diyabetik maküla ödemi tedavisinde intravitreal triamsinolon. T Oft Gaz 2003; 33: 488-497
  11. Martidis A, Düker JS, Greenberg PB, et al: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927
  12. Sakamoto T, Miyazaki M, Hisatomi T, et al: Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefe's Arch Clin Exp Ophthalmol 2002; 240: 423-429
  13. Lewis H: The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol 2001; 131: 123-125
  14. Menteş J.: Diabetik Makülopati ve Tedavisi. In Diabetik Retinopati. Özkan Ş, Akar S. Eds. İstanbul. Dilek Ofset. 2000:23-36
  15. Oik RJ: Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1986;93:938-950
  16. Natarajan S, Mehta H, Patel N, et al: Vitrectomy with intravitreal steroid. 4th European VitreoRetinal Society Meeting 2004, abstract book, 82
  17. Boscia F, Furino C, Recchimurzo N, et al: Internal limiting membrane peeling and intravitreal triamcinolone acetonide for refractory diabetic cystoid macular edema. 4th European ' VitreoRetinal Society Meeting 2004, abstrac